Axios @axios
A Senate deal to cap the cost of insulin at $35 a month for individuals with private insurance and Medicare poses a new test of whether Democrats can make good on campaign pledges to rein in drug costs. https://t.co/FSDCFXV7WL — PolitiTweet.org